Nobuhito Saito Selected Research

Cyclophilin C

6/2011	Cyclophilin C-associated protein regulation of phagocytic functions via NFAT activation in macrophages.
3/2005	Cyclophilin C-associated protein and cyclophilin C mRNA are upregulated in penumbral neurons and microglia after focal cerebral ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nobuhito Saito Research Topics

Disease

38	Neoplasms (Cancer) 07/2022 - 03/2002
19	Glioma (Gliomas) 01/2022 - 01/2002
18	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 03/2002
10	Germinoma 02/2022 - 07/2011
10	Ischemia 01/2021 - 06/2002
8	Hemorrhage 05/2016 - 12/2008
7	Ischemic Stroke 09/2022 - 12/2013
7	Meningioma (Meningiomas) 06/2022 - 07/2012
7	Aneurysm (Aneurysms) 01/2022 - 11/2010
6	Stroke (Strokes) 09/2022 - 03/2005
6	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2022 - 08/2015
6	Brain Neoplasms (Brain Tumor) 06/2021 - 03/2002
6	Drug Resistant Epilepsy 01/2021 - 09/2012
5	Pathologic Constriction (Stenosis) 01/2022 - 07/2012
5	Moyamoya Disease (Moya-Moya Disease) 11/2017 - 12/2012
5	Brain Ischemia (Cerebral Ischemia) 07/2012 - 03/2005
4	Hydrocephalus (Hydrocephaly) 01/2020 - 04/2010
4	Seizures (Absence Seizure) 09/2016 - 01/2011
4	Infarction (Infarctions) 12/2013 - 01/2006
3	Hematoma 01/2022 - 03/2006
3	Hemangioblastoma 01/2021 - 03/2002
3	Trigeminal Neuralgia (Tic Douloureux) 06/2020 - 08/2012
3	Oligodendroglioma 01/2019 - 07/2015
2	Neurofibromatosis 2 (Neurofibromatosis Type II) 05/2022 - 10/2021
2	Chondrosarcoma 02/2022 - 01/2018
2	Teratoma (Teratoid Tumor) 02/2022 - 03/2017
2	Carcinogenesis 01/2022 - 12/2017
2	Vascular Malformations 01/2022 - 03/2006
2	Arteriovenous Malformations (Arteriovenous Malformation) 12/2020 - 03/2020
2	Aortic Dissection 11/2020 - 01/2016
2	Chordoma 11/2020 - 01/2018
2	Intracranial Aneurysm (Cerebral Aneurysm) 03/2020 - 09/2014
2	Epilepsy (Aura) 01/2020 - 11/2011
2	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2012
2	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 10/2018 - 11/2017
2	Edema (Dropsy) 12/2016 - 04/2011
2	Rupture 09/2014 - 01/2011
2	Paresis (Hemiparesis) 02/2012 - 04/2010
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 02/2011 - 07/2007
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2008 - 02/2006
1	Heart Failure 09/2022
1	Vascular Diseases (Vascular Disease) 06/2022
1	Hyperemia 06/2022
1	Spontaneous Remission 06/2022
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2005
5	Biological ProductsIBA 06/2022 - 12/2017
5	Messenger RNA (mRNA)IBA 01/2021 - 03/2005
5	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2011
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2014
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2016 - 05/2008
3	Temozolomide (Temodar)FDA LinkGeneric 04/2015 - 01/2014
3	NestinIBA 03/2006 - 03/2002
2	Biomarkers (Surrogate Marker)IBA 06/2022 - 04/2018
2	Tumor Biomarkers (Tumor Markers)IBA 02/2022 - 12/2019
2	AntigensIBA 01/2022 - 02/2008
2	Dihydrotachysterol (AT 10)IBA 01/2021 - 12/2020
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 12/2017
2	Phosphotransferases (Kinase)IBA 01/2018 - 10/2005
2	ChromatinIBA 12/2017 - 01/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016 - 04/2011
2	SynaptophysinIBA 07/2015 - 07/2005
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 07/2015 - 03/2012
2	VaccinesIBA 02/2013 - 02/2008
2	Cyclophilin CIBA 06/2011 - 03/2005
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2011 - 03/2005
2	Epidermal Growth Factor (EGF)IBA 10/2010 - 05/2008
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2010 - 05/2008
2	Neuroprotective AgentsIBA 01/2006 - 03/2005
1	GadoliniumIBA 06/2022
1	Coloring Agents (Dyes)IBA 06/2022
1	dabrafenibIBA 01/2022
1	trametinibIBA 01/2022
1	N(6)-allyl-N(6)-cyclohexyladenosineIBA 01/2022

Therapy/Procedure

24	Therapeutics 07/2022 - 02/2008
17	Radiotherapy 02/2022 - 05/2003
13	Drug Therapy (Chemotherapy) 01/2022 - 04/2010
7	Aftercare (After-Treatment) 03/2016 - 09/2002
6	Electrodes (Electrode) 01/2020 - 02/2010
5	Stents 11/2020 - 01/2011
4	Thrombectomy 09/2022 - 04/2018
4	Catheters 01/2022 - 11/2010
4	Vagus Nerve Stimulation 01/2021 - 11/2011
4	Decompression 12/2020 - 08/2012
3	Precision Medicine 06/2022 - 01/2022
3	Ventriculoperitoneal Shunt 01/2020 - 04/2010
3	Craniotomy 01/2020 - 04/2010
3	Carotid Endarterectomy 10/2016 - 05/2013
3	Operative Surgical Procedures 12/2015 - 01/2011
2	Heart-Assist Devices 09/2022 - 01/2022
2	Decompressive Craniectomy 01/2022 - 01/2021
2	Renal Dialysis (Hemodialysis) 01/2021 - 04/2020
2	Adjuvant Radiotherapy 08/2018 - 06/2010
2	Ligation 04/2018 - 09/2014
2	Ventriculostomy 12/2015 - 04/2010
2	Embolectomy 10/2015 - 12/2013
2	Palliative Care (Palliative Therapy) 07/2013 - 01/2013
2	Laminectomy 01/2010 - 01/2004